HAYWARD, Calif.--(BUSINESS WIRE)--Protelica (formerly known as ProtElix, Inc.) is pleased to announce that it has received formal notification of Phase II SBIR funding by the National Science Foundation for its scientific project entitled “Bioinformatics knowledge-based, universal library design for a non-immunoglobulin, protein-scaffold.” The grant, effective January 15, 2009 provides $500,000 for the next 24 months and will allow the Company to continue developing its platform technology, and to fund preclinical studies of its early stage lead candidates for cardiovascular and cancer therapies.
